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Abstract
We report a molecular design that provides an intravenously injectable organic radical contrast
agent (ORCA) that has molecular r1 ≈ 5 mM−1s−1. The ORCA is based on spirocyclohexyl
nitroxide radicals and polyethylene glycol chains conjugated to a generation 4 polypropylenimine
dendrimers scaffold. The metal-free ORCA has a long shelf-life and provides selectively enhanced
MRI in mice for over 1 h.
Paramagnetic organic radicals, such as stable nitroxides, have been investigated as magnetic
resonance imaging (MRI) contrast agents.1–6 Metal-free, organic radical contrast agent
(ORCA) would provide an alternative to gadolinium-based contrast agents (GBCAs), which
are the most widely used paramagnetic metal ion-based agents in the clinic. Although
GBCAs are well tolerated by the majority of patients, patients with impaired kidney function
are reported to be at increased risk of developing a serious adverse reaction named
nephrogenic systemic fibrosis (NSF).7 Since the first report on this adverse effect in renal-
dialysis patients and its association with gadolinium,8,9 guidelines on the administration of
GBCAs have been issued and implemented worldwide to minimize the risk for NSF.
To date, the critical obstacle in the development of a practical ORCA for MRI is the design
and synthesis of paramagnetic compounds of moderate molecular size that possess long in
vivo lifetime, high 1H water relaxivity (r1), and high water solubility.1–6
Commonly used, paramagnetic nitroxides undergo fast reduction in vivo, especially in the
bloodstream and tissues, to diamagnetic hydroxylamines.2,3 For example, 3-carboxy-
2,2,5,5-tetramethyl-l-pyrrolidinyloxy (3-CP) (Scheme 1) and its derivatives, which are
among the most widely used and most resistant to reduction nitroxide radicals, have a short
half-life (ca. 2 min) in the bloodstream and kidneys, as determined by MRI mouse studies.2,3
Although nitroxides with one unpaired electron, total spin quantum number, S = ½, possess
low 1H water relaxivity,10 e.g. r1 ≈ 0.15 mM−1s−1 at 7 T for 3-CP, they have been utilized as
functional redox-sensitive agents in MRI studies, and as in vivo radioprotectors. 2,3,11 In
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principle, r1 could be increased by conjugation of paramagnetic metal chelates or radicals to
rigid scaffolds.12–14 However, previous examples of conjugation of nitroxides to dendrimers
did not provide increased r1,15,16 as shown in the case of the generation 3 (G3)
polypropylenimine (PPI) dendrimers conjugated with nitroxides 3-CP which has r1 ≈ 0.16
mM−1s−1 at 1.5 T, similar to that for common nitroxides. Despite low r1 and low solubility
in water,15 in vivo MR images of the rabbit stifle joints, obtained by intraarticular
administration of these agents, showed significant enhancement of articular cartilage in T1-
weighted images.1 Fast reduction and low r1 of nitroxides pose serious obstacles because
they severely limit available MR imaging time and contrast, while increasing dose of the
agent to compensate for reduction and low r1 could lead to oxidative stress.17 A practical
ORCA, especially suitable for intravenous injection, remains elusive.
We report a water-soluble ORCA with long in vivo lifetime and high r1 that provide
selectively enhanced MRI in mice for over 1 h.
Our approach to the design of ORCA relies on spirocyclohexyl nitroxide radical 1-OH
(Figure. 1). The 5-membered ring (pyrrolidinyl) nitroxide radical18,19 that is sterically
shielded20 by the spirocyclohexyl groups21 is expected to be reduced at a slower rate in
vivo, particularly by antioxidants such as ascorbate (vitamin C). Through judicious
molecular design, conjugation of nitroxide radicals to a rigid scaffold should provide an
agent with not only increased resistance to reduction but also with increased relaxivity. We
consider dendrimers (branched structures), which have been demonstrated to be more
effective as scaffold for linking Gd-chelates than linear structures in the approaches to
increased relaxivity of GBCAs.13,14,22 Because hydrophobicity of nitroxide- covered
dendrimer surface may contribute to limited applications of the agents in MRI, our approach
is aimed at alleviating that effect by including water solubilizing groups such as
polyethylene glycol (PEG) chains on the surface of the dendrimer. The non-immunogenic
and polar PEG chains may provide additional advantages,23 that is, the PEG chains may
help to immobilize nitroxides as well as increase water access to the paramagnetic nitroxides
that could help to increase r1. Our design strategy is to optimize the ratio of nitroxide and
PEG chains on the dendrimer surface to obtain ORCA with high r1 and good water
solubility. This concept is tested using PPI dendrimer conjugated with spirocyclohexyl
nitroxide 1 and hydrophilic, monodisperse methoxypolyethylene glycol (mPEG-12) chains
to obtain water soluble ORCA.
The spirocyclohexyl nitroxide 1-OH is synthesized by modification of methods for 3-CP,24
and then the carboxylic acid is converted to N-hydroxysuccinimidyl (NHS) ester, 1-NHS,
using standard methods. Sequential conjugation of 1-NHS, and mPEG-12-NHS to PPI
dendrimer generation-4 (PPI-G4) with 64 terminal amine groups ((NH2)i, i = 64) provides
ORCA 1-mPEG-G4. Through tests of various reaction conditions, it was determined that
using about 1/3 stoichiometric amount (1/3 equiv) of 1-NHS and an excess of 2/3 equiv of
mPEG-12-NHS is optimum. The resultant 1-mPEG-G4 has water solubility ≥0.5 g/mL and
radical concentration ≥0.4 mmol/g. ORCAs 1-mPEG-G3, 1-mPEG-G2, and 1-mPEG-G0, as
well as 3-CP-mPEG-G4 are prepared by analogous procedure (Table 1).
The number of conjugated spirocyclohexyl nitroxide 1 and mPEG-12 moieties per PPI
dendrimer core is determined using end group analysis based upon 1H NMR spectroscopy
and spin counting by EPR spectroscopy. Because 1H NMR spectra of paramagnetic ORCAs
are broad, and not useful for characterization, we convert the nitroxides to diamagnetic
hydroxylamines by treating the ORCAs with excess of ascorbate. The partially reduced
ORCAs provide sufficiently well resolved 1H NMR spectra for determination of the number
of conjugated mPEG-12 (m), by the relative integrals of 1H resonances for the terminal
methyl groups of mPEG-12 and the 1H resonances of the dendrimer scaffold. Spin counting
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provides the spin concentration of the ORCA sample (prior to treatment with ascorbate),
which can be used to determine the number of conjugated nitroxide radicals (j). The PPI
dendrimer surface coverage determined from the values of m and j is shown in Table 1. For
1-mPEG-G4, about 80% of the dendrimer surface is covered with nitroxides 1 and
mPEG-12 and this surface coverage increases to about 90% for lower generations of ORCA.
This incomplete surface coverage may be associated with well-known overcrowding on the
surfaces of the higher generation dendrimers25 that is further amplified by larger space
requirements of spirocyclic nitroxide vs. mPEG-12, as illustrated by the surface coverage of
64% and 92% for model compounds 1-G4 and mPEG-G4. Covalent attachment of both
mPEG-12 and the reduced nitroxides (hydroxylamines) to the scaffold is evidenced by two
broad 1H NMR peaks at δ 7.9 and δ 10.4 ppm (dimethylsulfoxide-d6), assigned to two
distinct NH amide groups. mPEG-G4 has only one type of NH amide group (singlet at δ 7.9
ppm), which shows a 1H-1H COSY cross-peak to the dendrimer backbone (Figures S10–
S18).
We investigate the rate of reduction of nitroxides 1-OH and ORCA 1-mPEG-G4 under
pseudo-first order conditions using 20-fold excess ascorbate in pH 7.4 PBS buffer. As
reference, the rate of reduction of 3-CP is determined under identical conditions. Second
order rate constants, k, are obtained by following the decay of the nitroxide EPR peak height
at 295 K (Figure 2A).
The spirocyclohexyl nitroxide, 1-OH (k = 0.031 ± 0.003 M−1s−1) is reduced at a
significantly slower rate than 3-CP (k = 0.063 ± 0.002 M−1s−1).19 Under similar conditions,
initial reduction of 1-mPEG-G4 occurs with the rate constant, k = 0.058 ± 0.004 M−1s−1,
which is comparable to that of 3-CP. However, after a fraction of nitroxides is reduced
during the initial 1-h period, the remaining nitroxides 1 on the crowded dendrimer surface
are reduced at about 20-fold slower rate (Table S2).
1H water relaxivity r1 of ORCAs and 3-CP in PBS buffer are measured using a 7-T MRI
scanner. The plots of 1/T1 (1H relaxation rate of water) vs. nitroxide concentration are linear
for all agents, indicating the absence of aggregation in the concentration range studied, 0–16
mM (per-nitroxide) (Fig. 2B). The slopes of the plots indicate that, under physiological
conditions (PBS, pH 7.2), 1H water relaxivity of PEGylated ORCAs is significantly higher
than for 3-CP. For example, r1 = 0.42 ± 0.03 mM−1s−1 per S = ½ nitroxide radical in 1-
mPEGG4, corresponding to molecular r1 ≈ 5 mM−1s−1, may be compared to 3-CP with r1 ≈
0.14 mM−1s−1 (Table 1). Solutions of 1- mPEG-G4 in PBS buffer are stable at room
temperature, with r1 showing negligible change over 24 h; similarly, no change is detected
in spin concentration by EPR spectroscopy for 1- mPEG-G4 in PBS buffer stored at −20 °C
for 5 months.
We examine rotational dynamics of the ORCA by EPR line-shape analysis. Because high
spin concentration leads to exchange broadening of EPR spectra, we decrease spin
concentration of ORCA, by treatment with ascorbate in PBS buffer, to obtain adequately
resolved EPR spectra for the analysis. Simulations of the EPR spectra of the partially
reduced ORCAs provide rotational correlation time (τrot) in the ns-range (Table 1),
compared to τrot = 0.045 ns for 3-CP under identical conditions. The value of τrot for 1-
mPEG-G4 is about 50% longer than that for 3-CP-mPEG-G4, emphasizing the effectiveness
of the spirocyclohexyl, and thus more rigid, structure of nitroxide 1 in restricting the motion
of the radical. Although the ORCA with the longest τrot = 1.5 ± 0.1 ns possesses the highest
r1, the relaxivity is only weakly dependent on τrot. This suggests the possibility of different
factors limiting r1 for the ORCAs, such as short electron spin relaxation time T1e and long
residence/exchange time (τexch) of water molecule hydrogen-bonded to the nitroxide radical.
Rajca et al. Page 3
J Am Chem Soc. Author manuscript; available in PMC 2013 September 26.
$watermark-text
$watermark-text
$watermark-text
EPR line-shape analyses for 1-mPEG-G4, -G3, and -G2 suggest that T1e is longer than about
20 ns, based upon the assumption T1e > T2e estimated from linewidths. Because the
dominant mechanism for shortening of T1e is by the modulation of electron-electron spin-
spin interaction by motion,26 the highly restricted motion of the radicals in the ORCAs (τrot
≈ 1 ns) is likely to prevent T1e from becoming sufficiently short, to affect water r1
significantly (Figure S22). This leaves long τexch as the most probable factor limiting water
r1, similar to the behavior observed in conjugates of Gd-chelates with dendrimers.27 The
dipolar inner sphere model,28 which is the standard in the analysis of Gd-chelates,13,22
predicts that shortened τexch ≤ 1 μs, i.e., improved access of water to radicals, should
facilitate increased water r1. For example, r1 ≈ 5 mM−1s−1 per S = ½ nitroxide radical is
computed for τexch ≈ 1 μs, τrot ≈ 1.5 ns, and T1e ≥ 20 ns (Figure S22).
To explore the potential of ORCAs as practical MRI contrast agents, we investigate 1-
mPEG-G4 in vivo. Since the r1 per S = ½ nitroxide radical for 1-mPEG-G4 is about 3 times
higher than for a typical nitroxide, we used a relatively small dose of radical, 0.5 mmol/kg,
which is 3 times less than the typical dose for common nitroxides in in vivo MRI studies.2,3
The T1 weighted high resolution 3D images of the mouse torso show that the 1-mPEG-G4 is
a long lasting blood pool contrast agent, which is slowly excreted through the kidneys
(Figures 3, 4, and Fig. S25). This can be appreciated in the subtraction images shown in
Figure 3B–D, F–H. It is clear that the liver and spleen show no appreciable uptake, only
residual signal as a result of the vasculature, while the lung, normally a low intensity organ
in MRI, lights up due to the enhancement of the vasculature.
The MRI signal in blood and kidneys decays gradually allowing for a long imaging time.
For example, the image enhancement (mean ± standard deviations, n = 3) in kidneys
medulla and blood vessels is 114 ± 14% and 81 ± 27% after 30 min following
administration of the agent and slowly decreases to 104 ± 11% and 60 ± 26% after 90 min of
scanning, respectively (Figure 4).
Although the present data do not allow for quantitation of the excretion of the agent,
selective uptake by the kidneys medulla and cortex, and the enhanced image of the bladder
(Figure 3), suggest excretion of ORCA through the kidneys. ORCA 1-mPEG-G4, with
average Mn ≈ 32 kDa (Table 1), is estimated to have a Stokes-Einstein radius (rSE) of about
2.4 nm, which is near the upper limit, rSE ≈ 2.5 nm, for glomerular filtration of positively
charged spherical solutes,29 and could thus account for strongly enhanced MR image of
kidneys, especially medulla, over a period exceeding 1 h (Table 1).
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Figure 1.
Organic radical contrast agent (ORCA).
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Figure 2.
(A) Reduction of 0.2 mM nitroxide radicals with 4 mM ascorbate in 125 mM PBS pH 7.4 at
295 K. (B) Plots of water 1H relaxation rates, 1/T1, vs. concentration of nitroxide radicals in
PBS pH 7.2; water relaxivities r1 determined from slopes of the linear fits (R2 = 0.998–
0.999).
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Figure 3.
3D T1 weighted spoiled gradient recalled echo MRI of mouse before and after injection of
1-mPEG-G4. (A,E) MRI before injection and (B–D,F–H): subtraction of preinjection images
from images obtained (B,D) 0–30 min, (C,E) 30–60 min, and (D,H) 60–90 min after
injection.
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Figure 4.
Plots of normalized intensities (mean ± standard errors, n = 3) before and after injection of
1-mPEG-G4.
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Scheme 1.
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Section 1. Materials, General Methods, and Instrumentation 
Note: Throughout the Supplementary Information, labels “yw0380B3” and alike 
correspond to sample or experiment codes directly traceable to the laboratory notebooks or raw 
data. 
All solvents were distilled, e.g., dimethylformamide (distilled under vacuum from 
calcium hydride), toluene (freshly distilled from sodium), and THF (freshly distilled from 
sodium benzophenone), or alternatively, obtained from solvent purification system (LC 
Technology Solutions).   N,N-Diisopropylethylamine (Hünig's base) was dried over calcium 
hydride, and then distilled.  Per-deuterated solvents for NMR spectroscopy were obtained from 
Cambridge Isotope Laboratories or Aldrich and used as received.  Monodisperse mPEG-12-NHS 
was obtained from Quanta BioDesign.  All other commercially available chemicals were 
obtained from either Aldrich or Fisher, unless indicated otherwise.   Column chromatography (0–
20 psig pressure) was carried out on flash silica gel (Sorbent Technologies).  Analytical and 
preparative glass plates (tapered with a preadsorbent zone) for thin layer chromatography (TLC) 
were obtained from Analtech.  Standard techniques for synthesis under inert atmosphere, using 
Schlenk glassware and gloveboxes (Vacuum Atmospheres), were employed for synthesis of 
ORCA. 
CW X-band EPR spectra for spin quantitation of nitroxide radicals and kinetics of 
reduction were acquired on a Bruker EMX instrument at Nebraska, equipped with a frequency 
counter and nitrogen flow temperature control (120–300 K).  The spectra were obtained using a 
Bruker TE102 cavity.  DPPH powder (g = 2.0037) was used as a g-value reference.  The spin 
concentration of low molecular weight nitroxide radicals and of nitroxide radicals in ORCA were 
measured in dichloromethane and PBS buffer at room temperature (295 K), respectively; 4-oxo-
TEMPO and/or 3-carboxy-PROXYL in respective solvents were used as intensity references.   
For low molecular weight nitroxide radicals, typical parameters were: modulation amplitude, 0.2 
G; sweep width, 100 G. 
1H NMR spectra were obtained with Bruker spectrometers (1H, 600, 500, and 400 MHz) 
using chloroform-d (CDCl3), water-d2 (D2O), dimethylsulfoxide-d6 (DMSO-d6), and acetone-d6 
as solvents.  (Spectra obtained in per-deuterated PBS buffer are labeled as obtained in D2O.)  The 
chemical shifts were measured with respect to residual solvent peak of chloroform-d ( 7.26 
ppm), dimethylsulfoxide-d6 ( 2.50 ppm) and acetone-d6 ( 2.05 ppm); for spectra in D2O or 
deuterated PBS buffer, the chemical shifts were referenced with respect to 0.05 wt% of 3-
(trimethylsilyl) propionic-2,2,3,3-d4 acid, sodium salt as the internal chemical shift standard (δ 
0.00 ppm).   IR spectra were obtained using a Nicolet Avatar 360 FT-IR instrument, equipped 
with an ATR sampling accessory (Spectra Tech, Inc.).  A few drops of the solution were applied 
to the surface of a ZnSe ATR plate horizontal parallelogram (45, Wilmad).  After the solvent 
evaporated, the spectrum was acquired (typically at 2-cm-1 resolution).  Mass spectra (MS) were 
obtained at the Nebraska Center for Mass Spectrometry.  Low molecular weight nitroxides were 
analyzed by fast atom bombardment (FAB) MS, using 3-nitrobenzyl alcohol (3-NBA) or 1-(2-
Nitrophenoxy)octane (Ortho-NitroPhenylOctylEther = ONPOE) as matrices, and electrospray 
ionization (ESI) MS, using sodium acetate in methanol/water. 
Water was purified using a Nanopure Water System (Barnstead).  Values of pH were 
measured using Corning pH/Ion Analyzer 350.  Dialyses of ORCA were carried out using 
GeBAFlex tubes with a cut-off molecular weight of 3500 Daltons.  
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Section 2.  Synthetic Protocols 
2.a Synthesis of nitroxide radicals 1-OH and 1-NHS.   Syntheses of 1 and 1-NHS are 
summarized by the equations below, and described in detail in the remainder of this subsection.  
The starting nitroxide radical 2 was prepared according to the literature procedure1,2.  Purity for 
all synthesized nitroxide radicals 2-Br, 1-OH, and 1-NHS is confirmed by EPR spectroscopic 
spin concentrations (90–100%) and paramagnetic 1H NMR spectra (Figs. S4, S7, and S8).  
      
Protocol for nitroxide 2-Br and its reduction to the corresponding hydroxylamine.     
Run No. 
SM (g/mmol) 
[mL of 
EtOH] 
HCl 
(mL/mmol) 
[mL of conc. 
HCl diluted 
to 10 mL 
with EtOH] 
Br2 
(mL/mmol)a Bromination 
1 M 
NaNO2  in 
H2O 
(mL/mmol) 
Yield 
(g/%) 
Spin 
Conc. 
(%) 
1 
1.000/4.00 
[5.0] 
2.4/5.2 
[1.82] 
3.65/4.0 
3 min at -100 
°C 25 min at  
r.t. 
3.5/3.5 0.687/52  
2 
0.917/3.67 
[4.5] 
2.3/4.8 
[1.75] 
2.01/3.7 3 min at -100 °C 25 min at r.t. 3.2/3.2 0.717/59  
3 
2.933/11.7 
[14] 
7.4/15.5 
[1.75] 
5.5/11.9 3 min at -100 °C 30 min at r.t. 10.2/10.2 1.865/48  
4 
1.618/6.46 
[6.5] 
4.0/8.4 
[1.74] 
4.0/6.5 3 min at -10 °C  30 min at r.t. 9/9 1.193/56  
5 
1.395/5.57 
[6.0] 
3.7/7.7 
[1.74] 
3.7/6.0 3 min at -10 °C 30 min at r.t. 12/12 1.109/60 94 
6 
1.125/4.49 
[4.6] 
2.8/5.8 
[1.74] 
2.2/3.6 3 min at -10 °C 32 min at r.t. 10/10 0.652/44  
a 1 – 2 M solutions of Br2 in CHCl3 
Procedure based on run no. 5.  Our procedure is based upon previous report for 
bromination of 4-oxo-TEMPO to the corresponding bromo-nitroxide3.   In a 25 mL conical flask, 
nitroxide radical 2 (1.395 g, 5.57 mmol) was suspended in ethanol (6.0 mL) and cooled in an ice 
water bath.  A solution of HCl (3.7 mL, 7.73 mmol, 1.3 equiv, made by diluting 1.74 mL of 
concentrated HCl to 10 mL with ethanol) was added and briefly stirred, forming a yellow 
colloid.  The reaction mixture was then stirred at room temperature for 90 min during which time 
the yellow colloid became white.  The reaction mixture was then concentrated under a stream of 
nitrogen, evacuated, and charged with nitrogen.  The resultant white solid was suspended in 
chloroform (4.2 mL), and cooled to –10 °C in an acetone/water ice bath, a solution of bromine in 
chloroform (3.7 mL, 6.0 mmol, 1.0 equiv, prepared by adding 5.0 mL of chloroform to 0.40 mL 
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of bromine) was added dropwise, forming a dark red solution.  The reaction mixture stirred at –
10 °C for 3 min, and then at room temperature for 30 min, over which time the solution became 
light brown.  Then, an aqueous solution of NaNO2 (1 M, 12 mL, 12 mmol, 2.0 equiv) was added 
and the reaction mixture immediately became dark brown and a brown gas was evolved. The 
reaction mixture was stirred at room temperature for 1 h, during which time the color became 
light orange.  The reaction mixture was transferred to a separatory funnel with chloroform (100 
mL) and washed with water (75 mL).  The organic layer was dried over anhydrous MgSO4 and 
concentrated with a rotatory evaporator.  The crude (2.096 g) was dissolved in 
chloroform/hexanes (1:1), and then purified by column chromatography (silica gel, hexanes/ethyl 
ether, 6:1)  Initially, a light yellow band, corresponding to an unknown by-product, is eluted, 
followed by the deep orange band of the product, which after evaporation of solvents, yields 
bromo-nitroxide 2-Br as a crystalline orange solid (1.109 g, 60%).  m.p. 83–86 °C.  IR (ZnSe, 
cm-1): 2927, 2858, 1717 (C=O), 1526, 1456, 1446, 1396, 1340, 1314, 1260, 1228, 1203, 1174, 
1063, 925, 856, 736, 705.  EPR (X-band): g = 2.0067, aN = 15.2 G, spin concentration = 94% 
(1.0 mM in CHCl3).  LR FAB-MS (ONPOE, negative ions): m/z ion type (%RA = percent 
relative amplitude for m/z 240–750) 330.0 [M+2H]– (100%), 331.9 [M+2+2H]– (100%).      
Reduction of bromo-nitroxide 2-Br to the corresponding hydroxylamine using 
phenylhydrazine.  Bromo-nitroxide 2-Br (2 mg) was dissolved in CDCl3 and the 1H NMR (400 
MHz) spectrum was obtained (label: JTP-3-100f1_before).  Then 6 drops of a solution of 
phenylhydrazine in CDCl3 (3 drops of phenylhydrazine in 1 mL CDCl3) was added and shaken 
for 10 minutes.  The solution lost its orange color and nitrogen was evolved.  1H NMR (400 
MHz) was obtained (label: JTP-3-100f1_after) showing formation of the corresponding 
diamagnetic hydroxylamine (Fig. S6). 
 
Protocol for nitroxide 1-OH. 
 
Run No. SM (g/mmol) 
KOH 
(mL/mmol)a 
Reaction 
Time       
(h) 
Yield 
(mg/%) 
1 0.287/0.872 12/43.6 37 78/34 
2 0.552/1.68 20/88.9 71 149/33 
3 0.521/1.58 20/87.0 30 169/40 
4 1.193/3.62 46/184 66 411/43 
5 0.308/0.935 11.7/45.6 112 147/59 
a 3.5 – 4.5 M solutions of KOH in water 
Procedure based on run no. 5.  Bromo–nitroxide 2-Br (308 mg, 0.935 mmol) was 
suspended in aq. KOH (4 M, 11.7 mL, 46.8 mmol) and stirred for five days in darkness.  After 
two days all starting material had dissolved giving a cloudy mixture with sticky red pieces of an 
unknown by product.  After three days, the solution was clear but the sticky pieces were still 
present.  After five days the reaction mixture was transferred to a separatory funnel and washed 
with chloroform (2 × 50 mL) removing a pink color.  The separatory funnel and chloroform 
solution were cooled in water ice, then an aqueous solution of NaHSO4 (1.5 M, 38 mL, 57 mmol) 
was added and immediately extracted with chloroform (6 × 100 mL).  The chloroform extracts 
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were combined, washed with water (250 mL) and dried over anhydrous MgSO4. Evaporation in 
rotary evaporator gave a crude solid (218 mg) which was dissolved in chloroform and purified 
by column chromatography (silica gel, chloroform/ethyl ether, 4:1).  The yellow product was the 
only visible band, which after evaporation gave nitroxide 1-OH as a yellow powder (147 mg, 
59%).  m.p. 191–193 °C.  EPR (X-band): g = 2.0064, aN = 14.6 G, spin concentration  100%.  
IR (cm-1): 2934, 2921, ~2900 (broad, COO-H), 2874, 2853, 1719 (C=O), 1449, 1410, 1312, 
1283, 1268, 1206, 1176, 1159, 1135, 907, 688, 671.  HR FAB-MS (matrix: 3-NBA): 268.1915 
(100%, [M+2H]+ -0.9 ppm for C15H26NO3), 267.1823 (9%, [M+H]+ 4.2 ppm for 
12C151H2514N16O3), 266.1759 (17%, [M]+ -1.0 ppm for 12C151H2414N16O3). 
Protocol for nitroxide 1-NHS. 
 
Run No. SM (mg/mmol) 
NHS 
(mg/mmol) 
DCC 
(mg/mmol) 
THF 
(mL) 
Reaction 
time (h) 
Yield 
(mg/%) 
Spin 
Conc. 
(%) 
1 123/0.462 41/0.356 98/0.475 4.0 67 
314/90 
 
2 132/0.496 59/0.513 105/0.509 6.0 72  
3 91/0.342 54/0.469 94/0.456 5.8 45 99/80  
4 39/0.146 28/0.243 45/0.218 2.6 71 47/88 98 
5 161/0.604 104/0.904 153/0.742 10.6 70 195/89 ~100 
Procedure based on run no. 5.  Nitroxide radical 1-OH (161 mg, 0.604 mmol), N-
hydroxysuccinimide (NHS, 104 mg, 0.904 mmol), and N,N'-dicyclohexylcarbodiimide (DCC, 
153 mg, 0.742 mmol) were charged to a 25 mL round bottom flask, briefly evacuated and filled 
with nitrogen.  THF (10.6 mL, freshly distilled from sodium and benzophenone) was added and 
the resultant yellow solution was stirred at r.t. protected from light for three days. After eight 
hours a precipitate formed which remained through work up.  After three days the reaction 
mixture was evaporated with a rotary evaporator and filtered through cotton with 
dichloromethane, evaporation of which yielded a crude solid (360 mg).  The crude was dissolved 
in chloroform and purified by column chromatography (silica gel, chloroform/acetone, 97:3).  
The product was eluted first as a yellow band followed by an orange band of by-product.  
Evaporation of solvents yielded active ester 1-NHS as a yellow-orange powder (195 mg, 89%).  
m.p. 182–184 °C.  EPR (X-band) g = 2.0065, aN = 14.6 G, spin concentration: ~100%.  IR 
(ZnSe, cm-1): 2930, 2858, 1809, 1782, 1737 (C=O), 1450, 1368, 1202, 1064, 1047, 993, 949, 
908, 894, 813, 752, 736, 646.  HR ESI-MS (MeOH/water, 3:1 and sodium acetate): 386.1814 
([M+Na]+ 0.5 ppm for C19H27N2O5Na).   
 
 
 
 
 
 
 
S6 
 
2.b EPR and 1H NMR spectroscopic analyses of nitroxide radicals   
 
Fig. S1. EPR (X-band) spectrum of 1.0 mM 2-Br in CHCl3 for determination of spin 
concentration (sample label: jtp-3-100f1, EPR label: JP532r7). 
 
Fig. S2. EPR (X-band) spectrum of 1.1 mM nitroxide radical 1-OH in CHCl3 for determination 
of spin concentration (sample label: JTP-4-08f1, EPR label: JP528r12). 
 
Fig. S3.  EPR (X-band) spectrum of 1.0 mM nitroxide radical 1-NHS in CHCl3 for determination 
of spin concentration (sample label: JTP-3-41f1, EPR label: JP528r10). 
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Fig. S4. 1H NMR spectrum (600 MHz, CDCl3) of bromo nitroxide 2-Br (sample and NMR label: 
JTP-3-100f1). 
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Fig. S5. 1H NMR spectrum (400 MHz, CDCl3) of dilute 2-Br prior to reaction with 
phenylhydrazine (NMR label: JTP-3-100f1_before). 
 
Fig. S6. 1H NMR spectrum (400 MHz, CDCl3) of the reaction mixture of 2-Br with 
phenylhydrazine (NMR label: JTP-3-100f1_after). 
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Fig. S7. 1H NMR spectrum (400 MHz, CDCl3) of nitroxide radical 1-OH (sample label: KW1-
57-lc2w).  
 
Fig. S8. 1H NMR spectrum (400 MHz, CDCl3) of nitroxide radical 1-NHS (sample label: KW1-
62-lc). 
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2.c Synthesis of organic radical contrast agents (ORCA). 
 Protocol for ORCAs based on 1-mPEG-G4.  PPI G4 dendrimer (33.6 mg, 4.70 μmol) and 
nitroxide radical 1-NHS (36.2 mg, 99.7 μmol, 21 equiv, sample label: jtp0269f1) were weighed 
in a glovebag, and then dried under high vacuum for overnight.  Then in the glovebag, a solution 
of PPI G4 dendrimer in anhydrous DMF (1.2 mL), and Hünig’s base (60.0 L, 73.5 equiv) were 
transferred to a Schlenk vessel.  The Schlenk vessel was attached to high vacuum line, and then 
nitroxide radical 1-NHS, as a solution in anhydrous DMF (0.4 mL) and anhydrous THF (0.4 
mL), was added dropwise under inert gas flow (nitrogen or argon).  The reaction mixture was 
lightly opaque during the addition of 1-NHS, but turned into a clear light yellow solution after 
stirring for 20 min.  After 6 days at room temperature in the absence of light, the homogenous 
reaction mixture was observed, though in some runs, a small amount of precipitate pasted on the 
wall of the Schlenk vessel was observed.  Then to this solution, mPEG-12-NHS (174.8 mg, 
267.2 μmol, 54 equiv) in anhydrous DMF (0.6 mL) was added.  The reaction mixture was stirred 
at ambient temperature in the absence of light for another 6 days.  The almost homogenous 
mixture with a small amount of suspended flocculent precipitate was centrifuged, and the 
precipitate was washed with DMF and centrifuged (×3).  The combined clear DMF solutions 
were concentrated under dry nitrogen gas flow.  Purification of the resultant clear pasty 
compound by dialysis (3500 D membrane) provided the product as yellow, clear, pasty solids 
with isolated yields of 81–97%.  In this particular run, 151.4 mg (88%) of 1-mPEG-G4 (sample 
label: yw0380B3) was obtained.   
Table S1.  Expanded version of Table 1 in the main text.    
Sample 
label ORCA G N 
x 
(nitroxide 
equiv) 
y 
(mPEG-12 
equiv) 
Spin Conc. 
(mmol g-1) 
R1     
(mM-1s-1)a 
rot 
(ns) 
j 
(radical) 
m 
(mPEG) m/j 
Surface 
Coverage 
(%) 
 yw0380B3 1-mPEG-G4 4 64 21 54 0.41 0.450 1.4 12.6 35.8 2.84 75.6 13.4 38.8 2.90 81.6 
yw0380A3 1-mPEG-G4 4 64 21 54 0.40 - - 12.4 36.0 2.90 75.3 
yw0339C3 1-mPEG-G4 4 64 21 54 0.42 - 1.5 - - - - 
yw0509A4 1-mPEG-G4 4 64 22 64 0.41 0.419 1.6 13.6 40.3 2.96 84.2 13.4 38.7 2.89 81.4 
yw0488-5 1-mPEG-G4 4 64 22 65 0.42 0.401 - - - - - 
yw0227-4 1-mPEG-G3 3 32 11 25 0.45 0.355 0.80 8 20 2.5 86 
yw0425-3 1-mPEG-G3 3 32 11 25 0.46 0.385 0.88   - - 
yw0387-4 1-mPEG-G2 2 16 6 15 0.48 0.304 0.50 4 10 2.5 90 
yw0427-3 1-mPEG-G2 2 16 6 15 0.43 0.282 0.47 - - - - 
yw0389cr2 1-mPEG-G0 0 4 1 5 0.23 0.211 0.25 - - - - 
yw0357-5 1-G4 4 64 70 0 2.38 - - 42 - 0 65 
yw0495-2 1-G4 4 64 80 0 2.34 - - 40 - 0 63 
yw0358-3 mPEG-G4 4 64 0 70 0 - - 0 59 - 92 
yw0233-5 3-CP-mPEG-G4 4 64 21 52 0.53 0.331 0.90 - - - - 
yw0419-3 3-CP-mPEG-G4 4 64 21 52 0.46 0.336 0.80 - - -  
3-Carboxy-
Proxyl 3-CP - - - - - 0.14 0.045 - - - - 
a R1 (mM-1s-1) per S = ½ nitroxide radical. 
Protocols for reduction of ORCA for the end group analysis by 1H NMR spectroscopy.  
Protocol based on the run with notebook label: yw03-99.  A sample of 1-mPEG-G4 (2.60 
mg, spin concentration of 0.41 mmol/g, sample label: yw03-80B-3) was placed in a vial and 
dissolved in PBS buffer (0.15 mL, 71.6 mM, 10.1 equiv, prepared from equivalent amount of 
Na2HPO4 and NaH2PO4) in D2O.  Then, 0.14 mL of this solution of 1-mPEG-G4 was transferred 
to 3-mm NMR tube, and then ascorbate (3.0 equiv, 20 μL of 150 mM solution in D2O was 
added. The mixture was shaken to make a homogenous solution and kept at ambient temperature 
with exclusion of light for 15 h.  1H NMR spectrum, obtained after the addition of 0.05 wt% 3-
(trimethylsilyl) propionic-2,2,3,3-d4 acid, sodium salt as the internal chemical shift standard (δ 
0.00 ppm), suggested that the degree of reduction was sufficient for the end group analysis.  
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Purification of the reaction mixture by dialysis (3500 D membrane, 8 h in pure water) was 
followed by concentration, and then drying under high vacuum overnight, to provide a yellow 
pasty product corresponding to the reduced 1-mPEG-G4 (1.92 mg, yield 74%, sample label: 
yw03-80B-3DR).  This product was re-dissolved into 0.15 mL of pure D2O and another 1H NMR 
spectrum was obtained; end group analysis based on integration of 1H NMR spectrum showed 
35.8 mPEG-12 moieties per ORCA (Fig. S10, top spectrum). 
Repeat run (notebook label: yw06-89) was carried out on the same sample of 1-mPEG-
G4 (sample label: yw03-80B-3) in PBS buffer (~85 μL of solution with spin concentration of 
106 mM), which was recovered from in vivo MRI experiments (the sample amount is equivalent 
to 22.0 mg of neat sample with spin concentration of 0.41 mmol/g).   Following the reaction with 
ascorbate, dialysis, concentration, and drying, the reduced 1-mPEG-G4 (16.2 mg, yield: 73%, 
label: yw03-80B-3DR2B) was obtained as a light brown pasty solid.  A 2.11 mg portion of the 
reduced product dissolved in D2O to obtain 1H NMR spectrum; end group analysis based on the 
integration of 1H NMR spectrum showed 38.8 mPEG-12 moieties per ORCA (Fig. S10, bottom 
spectrum).  The rest of the reduced product (13.7 mg) was dissolved in DMSO-d6 to obtain 1H 
NMR spectrum showing the two amide NH resonances at   7.9 and  10.4 ppm (see: main text 
and also Fig. S13 for a similar NMR spectrum on another sample).  (Attempts to obtain 1H-1H 
COSY and 1H-13C HMBC spectra in DMSO-d6 were not successful.)  Subsequently DMSO-d6 
was removed (concentration, brief dialysis, concentration, and drying), to provide recovered 
product (11.41 mg (label: yw03-80B-3DR2C).  This sample was then dissolved in 10% D2O in 
H2O, and another set of NMR spectra was obtained (Figs. S14 and S15). 
This protocol is for a different sample of 1-mPEG-G4; run with notebook label: yw05-23.  
Starting with 1-mPEG-G4 (3.23 mg, spin concentration of 0.41 mmol/g, sample label: yw05-
09A-4), the reduced 1-mPEG-G4 (2.70 mg, yield: 84%, label: yw05-09A-4DR) was obtained as 
a light brown pasty solid.   End group analysis based on integration of 1H NMR spectrum 
showed 40.3 mPEG-12 moieties per ORCA (Fig. S11, top spectrum).     
Repeat run (notebook label: yw06-96) was carried out on the same sample of 1-mPEG-
G4 (sample label: yw05-09A-4).  Starting with 1-mPEG-G4 (20.01 mg, spin concentration of 
0.41 mmol/g, label: yw05-09A-4), the reduced 1-mPEG-G4 (14.03 mg, yield: 70%, label: yw05-
09A-4DR3) was obtained as a brown pasty solid.  A 2.12-mg portion of the reduced product 
dissolved in D2O to obtain 1H NMR spectrum; end group analysis based on the integration of 1H 
NMR spectrum showed 38.7 mPEG-12 moieties per ORCA (Fig. S11, bottom spectrum).  Then 
in nitrogen gas filled glovebag, the rest of the compound (11.9 mg) was dissolved in 100%D 
DMSO-d6 (0.14 mL), and then 1H NMR spectra were obtained (Fig. S13).  (In COSY and 
HMBC experiments, cross-peaks could not be observed, perhaps due to aggregation of 1-mPEG-
G4 in either DMSO-d6 or DMSO-d6/chloroform-d mixtures (e.g., 2:1, 0.2 mL). 
Analogous protocols were used for reduction of 1-mPEG-G3 and 1-mPEG-G2; for 1H 
NMR spectra in D2O, see: Fig. S12. 
The NMR spectroscopic samples used for the end group analyses of 1-mPEG-G4, 1-
mPEG-G3 and 1-mPEG-G2 showed EPR spectra with significantly decreased linewidth and 
intensity, indicating partial reduction of nitroxide radicals.  Spin concentrations determined by 
EPR spectroscopy were in the 50–80% range of the values prior to the reduction and end group 
analysis. 
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End group analysis of ORCA: determination of number of nitroxide and mPEG-12 
moieties.  The number (m) of mPEG-12 moieties was calculated from 1H NMR spectra of 
completely reduced ORCA in D2O.  The calculation is based on the ratio of the integral for the 
sharp singlet at  3.39 ppm (CH3O group of mPEG-12) and half-peak integral of broad singlet at 
 1.91 ppm (CH2 groups of the dendrimer core).  For a sample of 1-mPEG-G4, integral at  3.39 
ppm was set to 3.00 protons and the integral at  1.91 ppm was found to be 3.46 protons, to give 
m = (3.00/3)/2×(3.46/248) = 35.8.   
Once the number m was determined, the number (j) of attached nitroxide moieties was 
calculated using spin concentration determined by EPR spectroscopy for ORCA in PBS buffer.  
The following relationship between spin concentration and the number j in 1-mPEG-G4 was 
used: 
Spin Conc. (mmol/g) = 1000×j/[7167.8546－(j+m)×1.0079 + j×249.3486 + m×571.6753] 
In the above relationship, 7167.8546, 1.0079, 249.3486, and 571.6753 are molecular 
weights (g/mol) of the dendrimer core, hydrogen atom, nitroxide 1 moiety, and mPEG-12 
moiety, respectively. 
As illustrated in Fig. S9, for a sample of 1-mPEG-G4 with m = 35.8 and spin 
concentration of 0.41 mmol/g, the value of j = 12.6 was found.  Similar procedure was 
implemented for the end group analyses of 1-mPEG-G3 and 1-mPEG-G2, as well as for model 
compounds 1-G4 and mPEG-G4.   
 
Fig. S9.  Plot of spin concentration versus the number (j) of attached nitroxide moieties for 
selected numbers of unreacted terminal amine groups (64 – m – j) for ORCA 1-mPEG-G4.  For 
an example sample, the value of j = 12.6 is determined based on independently measured spin 
concentration (EPR) and value of m (1H NMR) corresponding to the number of mPEG-12 
moieties. 
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2.d NMR and IR spectroscopic analyses of ORCA after reduction with ascorbate. 
 
 
Fig. S10.   1H NMR spectra (500 and 600 MHz, D2O) of reduced 1-mPEG-G4.  Top and bottom 
spectra: two reduction runs on the same sample of 1-mPEG-G4 (sample label: yw0380B3). 
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Fig. S11.   1H NMR spectra (500 and 600 MHz, D2O) of reduced 1-mPEG-G4.  Top and bottom 
spectra: two reduction runs on the same sample of 1-mPEG-G4 (sample label: yw0509A4). 
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Fig. S12.   1H NMR spectra (500 MHz, D2O) of reduced 1-mPEG-G3 (top spectrum) and 1-
mPEG-G2 (bottom spectrum) that were used for the end group analyses. 
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Fig. S13.   1H NMR spectrum (600 MHz, DMSO-d6) of reduced 1-mPEG-G4 (sample label 
before reduction: yw0509A4).  Peaks at  10.4 and  7.9 ppm were assigned to NH groups of the 
amide moieties connecting (reduced) nitroxides and mPEG-12 to the dendrimer core. 
 
Fig. S14.   1H NMR spectrum (600 MHz, 10% D2O in H2O) of reduced 1-mPEG-G4 (sample 
label before reduction: yw0380B3).   Peaks at  8.0 – 8.5 ppm were assigned to NH groups of the 
amide moieties. 
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Fig. S15.   1H NMR (top) and 1H-1H COSY (bottom) spectra (500 MHz, 10% D2O in H2O) of 
reduced 1-mPEG-G4 at 308 K (sample label before reduction: yw0380B3).   The cross-peak 
between the amide NH at  8.5 ppm and the NCH2 of the dendrimer core at  3.6 ppm is labeled 
with a blue arrow. 
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GPNAM2         sine.100
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P16             1000.00 usec
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WDW                  EM
SSB                   0
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PC                 0.50
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(COSY,308K,10%D2O,500MHz)
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Date_          20120709
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FnMODE      States-TPPI
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SSB                   2
LB                 0.00 Hz
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1H-1H COSY; 1-mPEG-G4: YW03-80B-3DR2C; 308.0 K, 11.4 mg in 0.15 mL: 10% D2O in H2O
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Fig. S16.   1H NMR (top) and 1H-1H COSY (bottom) spectra (600 MHz, DMSO-d6) of mPEG-
G4 (sample label: yw03583).  Peaks at  7.9 ppm and at  3.0 ppm, which have COSY cross-
peak (see: blue arrow), were assigned to the NH groups of the amide moieties connecting mPEG-
12 moieties to the dendrimer core and outermost NCH2 of the dendrimer core. 
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SSB                   0
LB                 0.30 Hz
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mPEG-G4: YW03-58-3; 27.28 mg in 0.5 mL DMSO
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NAME     yw03-58-3 (COSY)
EXPNO                 3
PROCNO                1
Date_          20120606
Time              16.11
INSTRUM           spect
PROBHD   5 mm PATXI 1H-
PULPROG        cosygpqf
TD                 2048
SOLVENT            DMSO
NS                   16
DS                   16
SWH            8992.806 Hz
FIDRES         4.391018 Hz
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Fig. S17.   1H NMR spectra (500 MHz, DMSO-d6) of PPI dendrimers G4 (top plot), G3 (middle 
plot), and G2 (bottom plot).   Peaks assigned to the terminal amine groups appear as broad 
singlet at approximately  1.5 ppm. 
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Fig. S18.   1H NMR spectra (500 MHz, D2O) of PPI dendrimers G4 (top plot), G3 (middle plot), 
and G2 (bottom plot). 
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Fig. S19.  IR (ZnSe, cm-1) spectra for 1-mPEG-G4 (top), -G3 (middle), and -G2 (bottom). 
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Fig. S20.  IR (ZnSe, cm-1) spectra for mPEG-G4 (top), 1-G4 (middle), and PPI-G4 dendrimer 
(bottom).   
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Section 3.  In Vitro Characterization 
3.a Kinetics of reduction of nitroxides with ascorbate.   The results of kinetic 
measurements are summarized in Table S2 (this Section).  The ascorbate solution was made with 
ascorbic acid, diethylenetriaminepentaacetic acid (DTPA, 0.1 mM), sodium hydroxide, and 
sodium phosphates (<30 ppm transition metals) at pH 7.4 (Corning pH/ion analyzer 350).  
Phosphate buffer was made with sodium phosphates and DTPA (0.1 mM) at pH 7.4 and used to 
make nitroxide solutions.  Reactions were carried out with a 20 times molar excess of ascorbate4.  
Nitroxide and ascorbate solutions were combined in equal portions and mixed for 6 
seconds.  The resultant solution was drawn into an EPR-quality quartz capillary tube (I.D. 0.5 
mm), and the capillary was stoppered with parafilm and placed in an EPR sample tube in the X-
band spectrometer cavity.  For low molecular weight nitroxide radicals, the peak height of the 
low-field line of the triplet was followed over time; the spectra were integrated to improve 
signal-to-noise as necessary.  For high molecular weight nitroxides, i.e., ORCA, the peak height 
of the low-field peak of the non-integrated spectrum was followed; signal-to-noise was improved 
by using higher concentrations (Table S2).  Microwave power was kept under 6.5 mW and 
temperature was controlled at 295 K with nitrogen flow system.   
Table S2.  Kinetics of nitroxide reduction with ascorbate under pseudo-first order conditions in 
PBS buffer with pH 7.4 at 295.0 K.  Kinetic data are summarized for nitroxide 3-CP, nitroxide 1, 
and ORCA 1-mPEG-G4.    
      Initial Kinetics 
(<1 h) 
Late Stage Kinetics 
 (after 1 h) 
Compd Sample 
Label 
Run 
No. 
Run 
Label 
Nitrox. 
Conc. 
(mM) 
Asc. 
Conc. 
(mM) 
k’  
× 104 
(s-1) 
R2 k 
(M-1s-1) 
Avg k 
(M-1s-1) 
k’ 
× 104 
(s-1) 
R2 k 
(M-1s-1) 
3-CP - 1 JP460 0.20 4.00 2.547 0.9996 0.06368 0.063  0.002    
3-CP - 2 JP461 0.20 4.00 2.498 0.9975 0.06246    
3-CP - 3 JP462 0.20 4.00 2.459 0.9999 0.06147 1.18 0.9952 0.030 
             
1 jtp0408f1 1 JP480 0.20 4.00 1.262 0.9976 0.03155 0.031  0.003    
1 jtp0408f1 2 JP481 0.20 4.00 1.142 0.9959 0.02854 0.708 0.9962 0.018 
1 jtp0408f1 3 JP482 0.20 4.00 1.259 0.9991 0.03147    
             
1-mPEG-G4 yw0380B3 1 JP609 0.50 10.0 6.196 0.9810 0.06196 0.058  0.004 0.29 0.9874 0.0029 
1-mPEG-G4 yw0380B3 2 JP610 0.50 10.0 5.420 0.9766 0.05420    
1-mPEG-G4 yw0380B3 3 JP611 0.50 10.0 5.725 0.9985 0.05725    
 
 
3.b Relaxivity (r1) and stability of ORCA.  The results of relaxivity (r1) measurements are 
summarized in Table S1 (Section 2).   
Relaxivity of ORCA.   Prior to relaxivity measurements, stock solutions of 3-CP, 1-
mPEG-G4, 1-mPEG-G3, 1-mPEG-G2, 1-mPEG-G0, and 3-CP-mPEG-G4 in PBS pH 7.2 were 
examined by EPR spectroscopy to determine spin concentrations.   Then, each stock solution was 
serially diluted with PBS pH 7.2 to provide 0.1-mL samples in 0.2-mL polypropylene centrifuge 
tubes, which were placed in a phantom holder.  MRI data were obtained using a 7 Tesla/16 cm 
scanner (Bruker Pharmascan) at room temperature.     
Stability of ORCA.   A stock solution of 1-mPEG-G4 (sample label: yw0509A4, spin 
conc. = 0.41 mmol/g) in PBS, pH 7.2 was determined to have spin concentration of 8.4 mM by 
EPR spectroscopy (EPR label: AO-8-25).   Serial dilution of the stock solution was followed by 
phantom relaxivity study, which showed no significant decrease of r1 over 29 h at room 
temperature (Fig. S21). 
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Fig. S21.  Plots of water 1H relaxation rates, 1/T1, vs. relative concentration of nitroxide radicals 
in 1-mPEG-G4 in PBS pH 7.2 after indicated period of time at room temperature.  Concentration 
range, determined by EPR spin concentration, 0 – 8.4 mM; magnetic field strength of 7 Tesla. 
A sample 1-mPEG-G4 (sample label: yw0380B3) in PBS (6.7 mM, pH 7.4), recovered 
after in vivo experiments, was determined to possess a spin concentration of 99 mM by EPR 
spectroscopy (reference: 3-CP)(EPR label: jtp-4-07).   After storing the sample for 5 months in a 
–20 C freezer, the spin concentration was 106 mM, i.e., unchanged within experimental error 
(EPR label: yw0689).       
3.c Rotational correlation times (rot), electron spin relaxation times (T1e and T2e), and 
factors limiting R1.   
Rotational correlation times.   Spin-labeled dendrimers were suspended in PBS buffer 
(pH 7.4) and reduced using a 3:1 molar ratio of ascorbic acid to spin label.  Reduction was 
needed to decrease the local nitroxyl concentration which causes significant exchange 
broadening of the CW EPR lineshape.  Spin label concentration was determined by comparison 
of CW EPR integrals with a nitroxyl standard.  Samples were reduced until the spin labeled 
concentration was approximately 100 M before spectra were recorded for simulation.  Room 
temperature CW EPR spectra were recorded on a Bruker EMX spectrometer at 9.8 GHz (X-
band) using 2 mW microwave power, 1 G modulation amplitude at 100 kHz, 1.28 ms time 
constant and 40.96 ms conversion time.  Between 5 and 25, 100 G scans were averaged 
depending on the concentration and extent of reduction of each sample.  Tumbling correlation 
times (rot) of the spin-labeled dendrimers were calculated by simulation of the CW EPR 
lineshapes using the chili toolbox of EasySpin5.  Linewidths of the center lines were manually 
adjusted and then held constant as the rot was varied to give the best fit to the low-field and high-
field lines. The results of rotational correlation times (rot) measurements are summarized in 
Table S1 (Section 2) and Figs. S23 and S24 in this Section. 
 Electron spin relaxation times (T1e and T2e).  In the tumbling ranges for these ORCA 
T1e is expected to be substantially longer than T2e, but that difference may be decreased by the 
electron-electron spin exchange.  The lineshapes for the EPR spectra of the spin-labeled 
dendrimers are not simple Lorentzians, which is attributed to a distribution of environments for 
the labels and unresolved hyperfine splittings.  When the lineshapes for 1-mPEG-Gn (n = 4, 3, 2) 
were approximated as Lorentzians, the linewidths ranged from 3.5 to 4 G, which corresponds to 
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T2e of 19 and 16 ns.  The constraint T1e > T2e then requires that T1e for these ORCA is longer 
than about 20 ns. 
 Factors limiting r1.  Analyses using equations S1–S4 (Fig. S22A), which are adopted as 
standard in the analysis of Gd-chelates, suggest that per-nitroxide r1 may be increased to values 
significantly greater than 0.4 mM-1s-1.  Similar to the gadolinium chelates, nitroxide radicals 
form complexes with at least one water molecule6.  According to eq. S1, longitudinal 1H water 
relaxivity (r1), i.e., per-nitroxide r1, is the sum of inner-sphere and outer-sphere contributions.  
The inner-sphere contribution is dominant, and thus by far the most important for optimization7.  
For nitroxide radicals, the primary inner sphere relaxation mechanism is the dipolar relaxation7,8.  
The same relaxation mechanism is expected in ORCAs, which may be considered as ensembles 
of weakly coupled, independent S = ½ radicals, analogous to S = 7/2 gadolinium chelates 
attached to dendrimers.  The dipolar inner sphere relaxivity (r1inner) of water (55.55 M) per S = ½ 
nitroxide is governed by standard equations S2, S3, and S4 (Fig. S22A)7,9. 
 Equations S2-S4 may be used to obtain plots of r1inner vs. exch for selected values of rot or 
T1e (Fig. S22B and S22C).  These plots of r1inner, which is expected to be the dominant 
contributor to r1,7 suggest that in order to account for the measured values of  r1  0.40 s-1mM-1 
observed for 1-mPEG-G4, exch has to be quite long, i.e., exch  50 s (very slow rate 1/exch).  
Calculations of r1inner also illustrate a potential, as well as limits, in optimization of r1.  For 
example, if water exchange rate (1/exch) can be increased so exch is shortened to about 1 s, a 
typical value for per-nitroxide, r1  5 s-1mM-1 is possible for an ORCA with rot  1.5 ns and T1e 
 20 ns.  
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 Fig. S22.  Factors limiting r1.   (A) Dipolar inner sphere model for water 1H relaxivity r1 per S = 
½ nitroxide radical.  (B) and (C) Plots of dipolar inner sphere relaxivity (r1inner) per S = ½ 
nitroxide radical versus residence time of water (exch) for selected values of T1e and rot. 
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Fig. S23.   CW EPR spectra of 1-mPEG-G4 (A), -G3 (B), -G2 (C) and -G0 (D) PPI dendrimers 
before (left) and after (right) reduction.  For reduced spectra, data (black) and EasySpin 
simulations (red) are shown.  
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Fig. S24.   CW EPR spectra of 3-CP-mPEG-G4 PPI dendrimers before (left) and after (right) 
reduction.  For reduced spectrum, data (black) and EasySpin simulations (red) are shown.  
 
Section 4.  In Vivo Characterization 
ORCA 1-mPEG-G4.   Solutions of 1-mPEG-G4 were prepared in physiological PBS, to 
obtain 120 mM spin concentration of S = ½ nitroxide radicals.  Volume of the injected solution 
was 110 L, corresponding to a dose of ~13 mol of S = ½ nitroxide radicals per mouse.  
Following the injections, spin concentration of each stock solution was verified by EPR 
spectroscopy.   
Mice.  MRI was performed on C57 Bl6 mice in this study in accordance with protocols 
approved by the Institutional Animal Care and Use Committee at the University of Nebraska 
Medical Center (UNMC).  Animals were obtained from the Jackson Laboratories (Bar Harbor, 
ME) and housed under specific pathogen-free conditions in accordance with the ethical 
guidelines for care of laboratory animals at UNMC and set forth by the National Institutes of 
Health. 
MRI acquisition.  Mice were anesthetized by inhalation of 1–2% isoflurane in a nitrous 
oxide/oxygen mixture before and during MRI data acquisition.  Before MRI, a catheter was 
implanted into the juglar vein of mice for infusions.  Then mice were placed in custom-build 
animal holders equipped with physiological monitoring and anesthesia delivery.  Respiratory 
monitoring was done using an SA instruments model 1025 MRI compatible physiological 
monitoring system (Model 1025, SA Instruments, Stony Brook, NY).  MRI data were obtained 
using a 7 Tesla/16 cm Bruker Pharmascan (Karlsruhe, Germany), with a 38 mm volume coil 
transmitter and receiver.  Whole body T1 weighted images were obtained using 3D FLASH with 
acquisition parameters of 50 x 40 x 20 mm field-of-view (FOV), a 256 x 196 x 128 matrix, 35° 
flip angle, 10 ms repetition time (TR), 2.7 ms echo time (TE), and six averages for a total 
acquisition time of 25 m 5.28 s.  Images were reconstructed to 256 x 256 x 256. 
S29 
 
Mouse MRI Data Analysis using ImageJ.  We measure Region of Interest (ROI) using 
Freehand and Rectangle Selections as shown in an example below. 
  
Freehand 
Selection 
("0107-0108-
0094") 
  X: 84 
  Y: 93 
  Width: 21 
  Height: 30 
Rectangle 
Selection 
("0107-0109-
0087") 
  X: 85 
  Y: 107 
  Width: 4 
  Height: 4 
 
 
 
Label  Area  Mean  StdDev  Mode  Min  Max  Circ  IntDen  RawIntDen  Slice  AR  Round Solidity 
2dseq_4_M35:0107‐0108‐0094:107  346  6399.673  575.321  6770  4700  7731  0.519  2214287  2214287  107  2.088  0.479  0.758 
2dseq_4_M35:0107‐0109‐0087:107  16  6988.312  253.759  6643  6643  7553  0.785  111813  111813  107  1  1.000  1 
 
Label  Area  Mean  StdDev  Mode  Min  Max  Circ  IntDen  RawIntDen  Slice  AR  Round Solidity 
2dseq_4_M35:0107‐0101‐0090:107  9  6468.556  264.464  5981  5981  6857  0.785  58217  58217  107  1  1.000  1 
2dseq_4_M35:0107‐0097‐0096:107  9  6600.556  160.854  6402  6402  6896  0.785  59405  59405  107  1  1.000  1 
2dseq_4_M35:0107‐0117‐0087:107  9  6640.667  148.082  6414  6414  6869  0.785  59766  59766  107  1  1.000  1 
2dseq_4_M35:0107‐0120‐0091:107  9  6398.444  253.029  5938  5938  6671  0.785  57586  57586  107  1  1.000  1 
2dseq_4_M35:0107‐0118‐0093:107  9  6507.111  253.589  6130  6130  6803  0.785  58564  58564  107  1  1.000  1 
2dseq_4_M35:0107‐0108‐0092:107  9  6394  289.544  5798  5798  6714  0.785  57546  57546  107  1  1.000  1 
2dseq_4_M35:0107‐0103‐0096:107  9  5251.111  189.447  5027  5027  5510  0.785  47260  47260  107  1  1.000  1 
2dseq_4_M35:0107‐0112‐0088:107  9  6916.778  186.480  6765  6765  7245  0.785  62251  62251  107  1  1.000  1 
2dseq_4_M35:0107‐0115‐0093:107  9  5592.778  177.281  5371  5371  5860  0.785  50335  50335  107  1  1.000  1 
2dseq_4_M35:0107‐0106‐0090:107  9  6538.889  185.376  6305  6305  6815  0.785  58850  58850  107  1  1.000  1 
2dseq_4_M35:0107‐0100‐0103:107  9  5974.556  287.192  5673  5673  6557  0.785  53771  53771  107  1  1.000  1 
2dseq_4_M35:0107‐0100‐0100:107  9  5810.889  284.878  5554  5554  6266  0.785  52298  52298  107  1  1.000  1 
2dseq_4_M35:0107‐0111‐0091:107  9  6463.778  286.124  6121  6121  7113  0.785  58174  58174  107  1  1.000  1 
Summary:                           
Mean  9  6273.701  228.180  5959.923  5959.923 6628.923 0.785  56463.308  56463.308  1  1  1   
SD  0  474.079  54.014  475.669  475.669  487.247  0  4266.711  4266.711  0  0  0   
Min  9  5251.111  148.082  5027  5027  5510  0.785  47260  47260  1  1  1   
Max  9  6916.778  289.544  6765  6765  7245  0.785  62251  62251  1  1  1   
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The average mean value (highlighted in blue), obtained from several areas with value of 
9, for time 0 (pre-injection), 30 min, 60 min and 90 min, of raw data are tabulated for selected 
organs (Blood, Kidney-Medulla, Kidney-Cortex, Liver, Muscle Tissue, and Bladder) for each 
mouse.  We normalize the mean values of a selected organ to that of Muscle Tissue which 
remain nearly constant over the time of the experiment.  The mean and standard error of 
normalized data for 3 mice are plotted in the Figure 4 (main text). 
 
 
 
Fig. S25.  Enlarged Figure 3 (main text).   3D T1 weighted spoiled gradient recalled echo MRI of 
mouse before and after injection of 1-mPEG-G4.  (A,E) MRI before injection and (B–D,F–H): 
subtraction of pre-injection images from images obtained (B,D) 0–30 min, (C,E) 30–60 min, and 
(D,H) 60–90 min after injection. 
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